Provectus' cool $1MM

Knoxville-based Provectus Pharmaceuticals announced a $1 million investment in the firm by Lincoln Park Capital Fund. Lincoln has promised an additional $30MM in equity investment, says the KNS.

Biopharma: GTx, Provectus report progress

Memphis-based GTx and Knoxville-based Provectus reported gains toward development of key products.

Provectus gets $5.3MM in PE transaction

[Updated March 12] Knoxville-based Provectus Pharmaceuticals will net about $5.3 MM after a private placement transaction, the company announced today. The company specializes in oncology and dermatological therapies. The release is here. In a March 12 release, Provectus said it expects to gross about $7.9 million on the transaction.

Provectus

Knoxville-based Provectus Pharmaceuticals, an OTCBB development-stage biotech company, announced today that Maxim, an analyst, has issued a report on the company and its prospects.